Literature DB >> 10229273

Changes in prevalence of herpes simplex virus type 1 and 2 antibodies from 1973 to 1993 in the rural districts of Japan.

M Hashido1, T Kawana, Y Matsunaga, S Inouye.   

Abstract

Using the gG-capture ELISA, changes in the seroprevalence of HSV-1 and HSV-2 from 1973 to 1993 were studied for 614 sera collected from general adults living in rural Japan. The HSV-1 seroprevalence for men and women decreased from 75.3 and 80.6% in 1973 to 54.4 and 59.6%, respectively, in 1993. The HSV-2 seroprevalence also decreased from 10.2 and 9.9% in 1973 to 1.8 and 1.2%, respectively, in 1993. Although the decrease in HSV-2 prevalence seemed to be correlated with the general decrease of sexually transmitted diseases in Japan since the 1950s, these findings should not be interpreted as typical, as HSV-2 infections are particularly known to distribute unevenly among populations, according to sexual activity and cohorts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229273     DOI: 10.1111/j.1348-0421.1999.tb02390.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  9 in total

Review 1.  Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection.

Authors:  Jie Zhang; Huan Liu; Bin Wei
Journal:  J Zhejiang Univ Sci B       Date:  2017 Apr.       Impact factor: 3.066

2.  Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM.

Authors:  James M Markert; Peter G Liechty; Wenquan Wang; Shanna Gaston; Eunice Braz; Matthias Karrasch; Louis B Nabors; Michael Markiewicz; Alfred D Lakeman; Cheryl A Palmer; Jacqueline N Parker; Richard J Whitley; George Y Gillespie
Journal:  Mol Ther       Date:  2008-10-28       Impact factor: 11.454

3.  A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.

Authors:  James M Markert; Shantanu N Razdan; Hui-Chien Kuo; Alan Cantor; Anette Knoll; Matthias Karrasch; L Burt Nabors; Michael Markiewicz; Bonita S Agee; Jennifer M Coleman; Alfred D Lakeman; Cheryl A Palmer; Jacqueline N Parker; Richard J Whitley; Ralph R Weichselbaum; John B Fiveash; G Yancey Gillespie
Journal:  Mol Ther       Date:  2014-02-27       Impact factor: 11.454

Review 4.  [Herpes simplex virus infections].

Authors:  G Gross
Journal:  Hautarzt       Date:  2004-09       Impact factor: 0.751

5.  Herpes simplex virus type-2 seropositivity among ever married women in South and north Vietnam: a population-based study.

Authors:  Hoa Van Le; Victor J Schoenbach; Rolando Herrero; Anh Thi Hoang Pham; Hieu Trong Nguyen; Thuy Thi Nguyen; Nubia Muñoz; Silvia Franceschi; Salvatore Vaccarella; Max D Parkin; Peter J F Snijders; Rhoda Ashley Morrow; Jennifer S Smith
Journal:  Sex Transm Dis       Date:  2009-10       Impact factor: 2.830

Review 6.  Recent progress in herpes simplex virus immunobiology and vaccine research.

Authors:  David M Koelle; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

7.  Herpes simplex virus type 1 infection in two pet marmosets in Japan.

Authors:  Kei Imura; James Kenn Chambers; Kazuyuki Uchida; Shunsuke Nomura; Satoshi Suzuki; Hiroyuki Nakayama; Yasutsugu Miwa
Journal:  J Vet Med Sci       Date:  2014-09-11       Impact factor: 1.267

8.  Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study.

Authors:  Dominique Bünzli; Vincent Wietlisbach; Fabrizio Barazzoni; Roland Sahli; Pascal R A Meylan
Journal:  BMC Infect Dis       Date:  2004-03-17       Impact factor: 3.090

9.  Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan.

Authors:  Yasufumi Doi; Toshiharu Ninomiya; Jun Hata; Koji Yonemoto; Yumihiro Tanizaki; Hisatomi Arima; Ying Liu; Mahbubur Rahman; Misuo Iida; Yutaka Kiyohara
Journal:  J Epidemiol       Date:  2009-03-06       Impact factor: 3.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.